insights_auto
Why is AKBA down 13,20%?
Dive Deeperchevron_right
AKBA:NASDAQ
Akebia Therapeutics Inc
US$0,50
arrow_downward
-13,20%(-0,076) 1D
US$0,51
arrow_upward
+2,17% (+0,011)bedtimeAfter hours
Closed: 12 ພ.ຈ., 16 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AKBA...
Open
US$0,57
High
US$0,57
Low
US$0,50
Mkt. cap
139,17 ລ້ານ
Avg. vol.
8,81 ລ້ານ
Volume
4,08 ລ້ານ
52-wk high
US$1,84
52-wk low
US$0,36
EPS
US$-0,16
Beta
0,24
Shares outstanding
277,66 ລ້ານ
No. of employees
194
Open
US$0,57
High
US$0,57
Low
US$0,50
Mkt. cap
139,17 ລ້ານ
Avg. vol.
8,81 ລ້ານ
Volume
4,08 ລ້ານ
52-wk high
US$1,84
52-wk low
US$0,36
EPS
US$-0,16
Beta
0,24
Shares outstanding
277,66 ລ້ານ
No. of employees
194
News stories
From web sources and news partners
Yahoo Finance
·
57 ນາທີກ່ອນ
Dow, S&P 500, Nasdaq Futures Edge Higher As Markets Attempt To Recover From Nvidia Rout: SLS, MSFT, CADL, MSTR In Focus
Eurasia Business News
·
4 ຊົ່ວໂມງກ່ອນ
Stock Market Today, November 12, 2026: Dow, S&P 500 and Nasdaq Fall After Jensen Huang Resigns
ChartMill
·
8 ຊົ່ວໂມງກ່ອນ
Most Active S&P 500 Stocks: KDP, Ford, AT&T Lead Today's Session
Traders Union
·
6 ຊົ່ວໂມງກ່ອນ
Jake Wujastyk: S&P 500 and ES_F trade within last Thursday's range for a full week
About Akebia Therapeutics Inc
CEO-
Employees194
Founded1 ມ.ກ. 2007
Headquartersແຄມບຣິກ, ມາຊາຊູເຊັດ, ສະຫະລັດ
SectorHealth Care
IndustryBiotechnology
Websiteakebia.com